Scarica l'app Stockscreener
2.39
0.42%
-0.010
Dopo l'orario di chiusura:
2.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.40
Aprire:
$2.41
Volume 24 ore:
113.42K
Relative Volume:
1.10
Capitalizzazione di mercato:
$98.00M
Reddito:
$2.70M
Utile/perdita netta:
$5.53M
Rapporto P/E:
21.73
EPS:
0.11
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
+0.00%
1M Prestazione:
-9.47%
6M Prestazione:
+3.02%
1 anno Prestazione:
+0.42%
Intervallo 1D:
$2.32
$2.41
Intervallo di 1 settimana:
$2.30
$2.43
Portata 52W:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Nome
Oramed Pharmaceuticals Inc
Settore
Industria
Telefono
646-844-1164
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Confronta ORMP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.39 | 98.41M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-09 | Iniziato | National Securities | Buy |
| 2020-12-03 | Iniziato | Alliance Global Partners | Buy |
| 2020-03-11 | Iniziato | Aegis Capital | Buy |
| 2019-09-11 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-12-11 | Ripresa | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Reiterato | FBR Capital | Outperform |
| 2015-12-01 | Reiterato | H.C. Wainwright | Buy |
| 2015-11-19 | Iniziato | FBR Capital | Outperform |
| 2015-04-13 | Ripresa | MLV & Co | Buy |
| 2014-01-30 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Reiterato | Aegis Capital | Buy |
| 2014-01-08 | Iniziato | MLV & Co | Buy |
| 2013-12-03 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie
Why Oramed Pharmaceuticals Inc. stock is a must watch in 20252025 Valuation Update & Community Supported Trade Ideas - newser.com
Is Oramed Pharmaceuticals Inc a good long term investmentMoving Average Strategies & Superior Growth Investment - earlytimes.in
Is Oramed Pharmaceuticals Inc. stock a defensive play in 20252025 Geopolitical Influence & Community Consensus Trade Signals - newser.com
Ranking Oramed Pharmaceuticals Inc. among high performing stocks via toolsPortfolio Return Report & Weekly Market Pulse Updates - newser.com
Pattern recognition hints at Oramed Pharmaceuticals Inc. upsideQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
What does recent volatility data suggest for Oramed Pharmaceuticals Inc.July 2025 Closing Moves & Free High Return Stock Watch Alerts - newser.com
Why Oramed Pharmaceuticals Inc. (OJU1) stock fits value portfolios2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Using Ichimoku Cloud for Oramed Pharmaceuticals Inc. technicalsWeekly Profit Report & Verified Stock Trade Ideas - newser.com
Will Oramed Pharmaceuticals Inc. benefit from macro trends2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com
How Oramed Pharmaceuticals Inc. stock reacts to global recession fearsMarket Activity Report & Weekly Chart Analysis and Guides - newser.com
Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growthEarnings Miss & Real-Time Volume Trigger Notifications - newser.com
Applying sector rotation models to Oramed Pharmaceuticals Inc.July 2025 Review & Weekly High Potential Alerts - newser.com
Is Oramed Pharmaceuticals Inc. (OJU1) stock resilient in recession scenariosWeekly Volume Report & Growth Focused Investment Plans - newser.com
Custom watchlist performance reports with Oramed Pharmaceuticals Inc.Weekly Volume Report & Real-Time Volume Trigger Notifications - newser.com
Can technical indicators confirm Oramed Pharmaceuticals Inc.’s reversal2025 Price Action Summary & AI Driven Price Forecasts - newser.com
What recovery options are there for Oramed Pharmaceuticals Inc.July 2025 Analyst Calls & High Yield Equity Trading Tips - newser.com
Will Oramed Pharmaceuticals Inc. stock continue upward momentumEarnings Miss & Real-Time Sentiment Analysis - newser.com
Will breakout in Oramed Pharmaceuticals Inc. lead to full recoveryJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Tools to assess Oramed Pharmaceuticals Inc.’s risk profileJuly 2025 Technicals & High Conviction Buy Zone Alerts - newser.com
Oramed Pharm Repurchases Shares, Ends Joint Venture - MSN
Why Oramed Pharmaceuticals Inc. stock remains undervaluedPortfolio Risk Summary & Growth Focused Stock Reports - newser.com
Oramed Pharmaceuticals (ORMP) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Visualizing Oramed Pharmaceuticals Inc. stock with heatmapsQuarterly Profit Review & Low Risk Entry Point Guides - newser.com
Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):